Skip to main content

Table 2 Recurrent Neurologic Event Rate

From: Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder

Study TIA Ischemic Stroke Follow-Up Period
RESPECT Trial (AmplatzerTM)9 6/499 (1.2 %) 9/499 (1.8 %) 2.6 years (mean)
PC Trial (AmplatzerTM)11 5/204 (2.5 %) 1/204 (0.5 %) 4.1 years (mean)
CLOSURE I Trial (STARFlex®)10 13/447 (3.1 %)a 12/447 (2.9)a 2 years
Fischer et al. (AmplatzerTM)27 2/113 (1.8 %) 1/113 (0.9 %) 17.7 months (mean)
Krizianic et al. (Figulla® N)23 0/34 (0 %) 1/34 (2.9 %) 6 months
Aytemir et al. (Figulla®)19 1/85 (1.2 %) 0/85 (0 %) 17.0 months (mean)
  1. aIntention-to-treat-population